118. Myelomeningocele Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 6 Drugs : 9 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 12

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Anticholinergic
   Assiut University
      2024   -   NCT06301802   Egypt
Atosiban
   University of Sao Paulo General Hospital
      2017   -   NCT04468568   Brazil
Botulinum A toxin
   University of Aarhus
      2005   Phase 4   NCT00175123   Denmark
CIC
   Assiut University
      2024   -   NCT06301802   Egypt
Contrast enhanced voiding urosonography with urodynamic testing
   University of Virginia
      2021   -   NCT04738539   United States
Monitor
   Marmara University
      2016   -   NCT04186338   -
Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix
   University of California, Davis
      2021   Phase 1/Phase 2   NCT04652908   United States
Terbutaline
   University of Sao Paulo General Hospital
      2017   -   NCT04468568   Brazil
Untreated contemporaneous cohort
   University of California, Davis
      2021   Phase 1/Phase 2   NCT04652908   United States